Tom Blackburn (pharmacologist)

Tom Blackburn FBPharmacolS, FRSB (born 1949) is a British industrial pharmacologist.

Tom Blackburn

Born1949 (age 7374)
NationalityUnited Kingdom
Alma mater
OccupationIndustrial pharmacologist
Employers

Blackburn studied at both the University of Nottingham and Manchester University, and worked as a senior manager at ICI Pharmaceuticals, Beecham Pharmaceuticals SmithKline Beecham, Synaptic Pharmaceutical Corporation and Helicon Therapeutics.[1]

He is the author of over 100 scientific papers, reviews and book chapters and holds over 20 patents.[1] He is President Emeritus of the British Pharmacological Society and is a member of the American College of Neuropsychopharmacology.[1]

He was elected an Honorary Fellow of the British Pharmacological Society (Hon FBPharmacolS) in 2014 and is a Fellow of the Royal Society of Biology (FRSB).[2]

References

  1. Caroline Overy; Tilli Tansey, eds. (2013). Drugs Affecting 5-HT Systems. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-0-902238-87-9. Wikidata Q29581800.
  2. "Dr Thomas Blackburn". British Pharmacological Society. Retrieved 3 August 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.